Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Orr

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Cell Host & Microbe|November 17, 2007
CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class IMark T Orr, Meredith A Mathis, Michael Lagunoff, et al.
Immunity|March 29, 2011
CD94 is essential for NK cell-mediated resistance to a lethal viral diseaseMin Fang, Mark T Orr, Pieter Spee, et al.
Plos Pathogens|October 5, 2005
Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of miceMark T Orr, Kurt H Edelmann, Jeffrey Vieira, et al.
NPJ Vaccines|June 1, 2019
The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccineHong Liang, David Poncet, Emilie Seydoux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2015
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic MechanismRhea N Coler, Thomas Hudson, Sean Hughes, et al.
Pharmaceutics|December 23, 2022
Formulated Phospholipids as Non-Canonical TLR4 AgonistsHong Liang, William R Lykins, Emilie Seydoux, et al.
Nanoscale|January 14, 2020
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cellsAmit P Khandhar, Hong Liang, Adrian C Simpson, et al.
European Journal of Immunology|December 15, 2018
Memory CD4<sup>+</sup> T cells enhance B-cell responses to drifting influenza immunizationEmily Gage, Neal Van Hoeven, Natasha Dubois Cauwelaert, et al.
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
European Journal of Immunology|October 5, 2016
Antigen presentation by B cells guides programing of memory CD4<sup>+</sup> T-cell responses to a TLR4-agonist containing vaccine in miceNatasha Dubois Cauwelaert, Susan L Baldwin, Mark T Orr, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cell Host & Microbe|November 17, 2007
CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class IMark T Orr, Meredith A Mathis, Michael Lagunoff, et al.
Immunity|March 29, 2011
CD94 is essential for NK cell-mediated resistance to a lethal viral diseaseMin Fang, Mark T Orr, Pieter Spee, et al.
Plos Pathogens|October 5, 2005
Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of miceMark T Orr, Kurt H Edelmann, Jeffrey Vieira, et al.
NPJ Vaccines|June 1, 2019
The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccineHong Liang, David Poncet, Emilie Seydoux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2015
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic MechanismRhea N Coler, Thomas Hudson, Sean Hughes, et al.
Pharmaceutics|December 23, 2022
Formulated Phospholipids as Non-Canonical TLR4 AgonistsHong Liang, William R Lykins, Emilie Seydoux, et al.
Nanoscale|January 14, 2020
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cellsAmit P Khandhar, Hong Liang, Adrian C Simpson, et al.
European Journal of Immunology|December 15, 2018
Memory CD4<sup>+</sup> T cells enhance B-cell responses to drifting influenza immunizationEmily Gage, Neal Van Hoeven, Natasha Dubois Cauwelaert, et al.
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
European Journal of Immunology|October 5, 2016
Antigen presentation by B cells guides programing of memory CD4<sup>+</sup> T-cell responses to a TLR4-agonist containing vaccine in miceNatasha Dubois Cauwelaert, Susan L Baldwin, Mark T Orr, et al.
Pageof 5